Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

C-Section blood thinner trial: is it worth the risk?

NCT ID NCT06118957

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times

Summary

This study looked at whether it's practical to give a blood thinner (enoxaparin) to women after a C-section to prevent blood clots. Researchers wanted to see if enough women would join the study and stick with it. 64 women took part, and the goal was to have at least 35% enroll and 85% complete the study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THROMBOEMBOLISM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Utah

    Salt Lake City, Utah, 84132, United States

Conditions

Explore the condition pages connected to this study.